Welcome to the Psoriasis Program at the University of Colorado! Our mission is to
provide exceptional care to
patients with psoriatic diseases and lead psoriasis research. Psoriasis
is a chronic, inflammatory skin disease that affects 3.2% of the U.S.
population and nearly 8 million Americans. It is associated with significant physical and
psychosocial burden. Here at the University of Colorado, we know that psoriasis
is more than skin deep. Approximately 30% of psoriasis patients have
psoriatic arthritis, and many suffer from cardiovascular diseases to a greater extent than the general population. Importantly, psoriasis can
significantly impact patients’ emotional and social wellbeing. We are here to ensure that our psoriasis patients receive the highest-quality care and have the unique opportunity to participate in clinical studies with the latest therapeutic advances.
Psoriasis Care at the University of Colorado:
We are dedicated to improving the lives of patients with psoriatic
diseases through comprehensive care and advanced research. Our physicians are
leading experts in the field of psoriasis, psoriatic arthritis,
and other medical conditions associated with psoriasis. We adopt an evidence-based approach to treatments, and we work with patients individually to deliver optimal personalized care. All therapeutic options are made available to our patients,
including topical treatments, phototherapy, oral systemic medications,
and biologic therapies. Our office staff advocate for our patients' needs and coordinate with our patients' insurance provider to obtain coverage for their
We have a premiere
psoriasis research program with both federally funded and
industry-sponsored clinical trials in psoriasis and psoriasis comorbidities. Our
scientists study psoriasis pathogenesis with advanced translational
techniques and animal modeling. We also study health outcomes that are relevant to patients, providers, and other stakeholders, and are constantly searching for new ways to improve access and quality of life for our psoriasis patients. We continually search for novel ways of
improving health services delivery for psoriasis patients. We are active in clinical trials, evaluating the latest medical advances to treat psoriatic diseases.
Our patients not only have the opportunity to contribute to scientific
discovery in psoriasis; they also may qualify to receive medical care and
psoriasis medications at no cost through some clinical trials.
Dr. April Armstrong
directs the psoriasis program at University of Colorado. The psoriasis program consists
of eight faculty members from multiple disciplines including dermatology,
dermatopathology, rheumatology, and cardiology, with complementary expertise in
clinical care, epidemiology, health outcomes research,
and translational research. The psoriasis program is also supported by professional
research staff and qualified medical